INS and type 2 diabetes mellitus: Disrupting insulin binding to receptors inhibits the initial step of the insulin signaling pathway, which may result in reduced glucose uptake by muscle tissues and may exacerbate β-cell function, leading to insulin resistance and type 2 diabetes [35].